Secondary hyperparathyroidism: Review of the disease and its treatment
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 26 (12) , 1976-1993
- https://doi.org/10.1016/j.clinthera.2004.12.011
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysisKidney International, 2003
- Long‐term impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end‐stage renal failure patientsNephrology Dialysis Transplantation, 2002
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Cutaneous CalciphylaxisAmerican Journal of Clinical Pathology, 2000
- Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patientKidney International, 1999
- Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidismAmerican Journal of Kidney Diseases, 1996
- High Frequency of Marked Hyperphosphatemia during Intravenous Calcitriol Therapy in Hemodialysis Patients with Refractory HyperparathyroidismBlood Purification, 1996
- Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patientsAmerican Journal of Kidney Diseases, 1995
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patientsKidney International, 1992
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989